Difference between revisions of "Lundbeck"
Josh Leeson (talk | contribs) (→Lobbying firms) |
|||
Line 27: | Line 27: | ||
==Drugs== | ==Drugs== | ||
[[Nalmefene]] | [[Nalmefene]] | ||
+ | |||
+ | ==Affiliations== | ||
+ | Lundbeck pays the charity [[Alcohol Concern]] an annual grant to act as secretariat to the Westminster-based [[All-Party Parliamentary Group on Alcohol Harm]]. | ||
==Contact== | ==Contact== |
Latest revision as of 10:51, 12 November 2015
H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research and development, production, marketing, and sale of drugs for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia.[1]
Contents
People
Executive management
- Ulf Wiinberg - Chief Executive Officer
- Anders Gersel Pedersen - Executive Vice President
- Anders Götzsche - Executive Vice President, CFO
Board of Directors
- Håkan Björklund - Chairman, Remuneration Committee; Member, Audit Committee
- Christian Dyvig -Member, Remuneration & Scientific Committee
- Thorleif Krarup -Chairman, Audit Committee
- Melanie G. Lee - Member, Scientific Committee
- Jes Østergaard - Chairman, Scientific Committee
- Lars Rasmussen - Member, Audit & Remuneration Committee
- Mona Elisabeth Elster - Employee representative
- Jørn Mayntzhusen - Employee representative
- Kim Rosenville Christensen - Employee representative
Lobbying firms
2014
Drugs
Affiliations
Lundbeck pays the charity Alcohol Concern an annual grant to act as secretariat to the Westminster-based All-Party Parliamentary Group on Alcohol Harm.
Contact
- H. Lundbeck A/S
- Ottiliavej 9 2500 Valby Denmark
- Phone +45 3630 1311
- Fax: +45 3630 1940
- www.lundbeck.com
Notes
- ↑ About Us, Lundbeck.com.
- ↑ Agency Register September to November 2014 PRCA, accessed 27 January 2015
- ↑ Register 1st September 2014 - 30th November 2014 APPC, accessed 23 February 2015